134 related articles for article (PubMed ID: 8319584)
21. Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice.
Steinhelper ME; Lanson NA; Dresdner KP; Delcarpio JB; Wit AL; Claycomb WC; Field LJ
Am J Physiol; 1990 Dec; 259(6 Pt 2):H1826-34. PubMed ID: 2175567
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.
Hoffmann S; Krause T; van Geel PP; Willenbrock R; Pagel I; Pinto YM; Buikema H; van Gilst WH; Lindschau C; Paul M; Inagami T; Ganten D; Urata H
J Mol Med (Berl); 2001 Oct; 79(10):601-8. PubMed ID: 11692158
[TBL] [Abstract][Full Text] [Related]
23. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
[TBL] [Abstract][Full Text] [Related]
24. Distinct regulation of developmental and heart disease-induced atrial natriuretic factor expression by two separate distal sequences.
Horsthuis T; Houweling AC; Habets PE; de Lange FJ; el Azzouzi H; Clout DE; Moorman AF; Christoffels VM
Circ Res; 2008 Apr; 102(7):849-59. PubMed ID: 18276916
[TBL] [Abstract][Full Text] [Related]
25. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
[TBL] [Abstract][Full Text] [Related]
26. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
27. Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes.
Katz EB; Steinhelper ME; Delcarpio JB; Daud AI; Claycomb WC; Field LJ
Am J Physiol; 1992 Jun; 262(6 Pt 2):H1867-76. PubMed ID: 1377879
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor-1 overexpression in cardiomyocytes diminishes ex vivo heart functional recovery after acute ischemia.
Prêle CM; Reichelt ME; Mutsaers SE; Davies M; Delbridge LM; Headrick JP; Rosenthal N; Bogoyevitch MA; Grounds MD
Cardiovasc Pathol; 2012; 21(1):17-27. PubMed ID: 21266309
[TBL] [Abstract][Full Text] [Related]
29. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
[TBL] [Abstract][Full Text] [Related]
30. Serum from patients with chronic renal insufficiency alters growth characteristics and ANP mRNA expression of adult rat cardiac myocytes.
Yu JZ; Bondy GP; Allard MF; Thompson CR; Levin A; McManus BM
J Mol Cell Cardiol; 1996 Dec; 28(12):2429-41. PubMed ID: 9004160
[TBL] [Abstract][Full Text] [Related]
31. Adenoviral expression of calmodulin antisense reduces hypertrophy in cultured cardiomyocytes.
Arruda LH; Cestari IA; Leirner AA; Cestari IN
Artif Organs; 2007 Apr; 31(4):274-7. PubMed ID: 17437495
[TBL] [Abstract][Full Text] [Related]
32. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
[TBL] [Abstract][Full Text] [Related]
33. Cardiomyocyte cell cycle activation ameliorates fibrosis in the atrium.
Nakajima H; Nakajima HO; Dembowsky K; Pasumarthi KB; Field LJ
Circ Res; 2006 Jan; 98(1):141-8. PubMed ID: 16306446
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous activity in transgenic mouse heart: comparison of primary atrial tumor with cultured AT-1 atrial myocytes.
Kline RP; Sorota S; Dresdner KP; Steinhelper ME; Lanson NA; Wit AL; Claycomb WC; Field LJ
J Cardiovasc Electrophysiol; 1993 Dec; 4(6):642-60. PubMed ID: 8305985
[TBL] [Abstract][Full Text] [Related]
35. Effects of changes in calmodulin levels on cell proliferation.
Rasmusen CD; Means AR
Environ Health Perspect; 1990 Mar; 84():31-4. PubMed ID: 2190816
[TBL] [Abstract][Full Text] [Related]
36. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart.
Nakajima H; Nakajima HO; Salcher O; Dittiè AS; Dembowsky K; Jing S; Field LJ
Circ Res; 2000 Mar; 86(5):571-9. PubMed ID: 10720419
[TBL] [Abstract][Full Text] [Related]
37. Innervating sympathetic neurons regulate heart size and the timing of cardiomyocyte cell cycle withdrawal.
Kreipke RE; Birren SJ
J Physiol; 2015 Dec; 593(23):5057-73. PubMed ID: 26420487
[TBL] [Abstract][Full Text] [Related]
38. Heart-specific activation of LTK results in cardiac hypertrophy, cardiomyocyte degeneration and gene reprogramming in transgenic mice.
Honda H; Harada K; Komuro I; Terasaki F; Ueno H; Tanaka Y; Kawamura K; Yazaki Y; Hirai H
Oncogene; 1999 Jul; 18(26):3821-30. PubMed ID: 10445845
[TBL] [Abstract][Full Text] [Related]
39. Cardiac striatin interacts with caveolin-3 and calmodulin in a calcium sensitive manner and regulates cardiomyocyte spontaneous contraction rate.
Nader M; Alotaibi S; Alsolme E; Khalil B; Abu-Zaid A; Alsomali R; Bakheet D; Dzimiri N
Can J Physiol Pharmacol; 2017 Oct; 95(10):1306-1312. PubMed ID: 28825318
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth.
Chen H; Yong W; Ren S; Shen W; He Y; Cox KA; Zhu W; Li W; Soonpaa M; Payne RM; Franco D; Field LJ; Rosen V; Wang Y; Shou W
J Biol Chem; 2006 Sep; 281(37):27481-91. PubMed ID: 16798733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
